Trial · NCT03711162
Adverse events300
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 300
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | GLPG1690 600 mg | 51 | 174 | 111 |
| other | Diarrhoea | Gastrointestinal disorders | GLPG1690 200 mg | 40 | 175 | 84 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 20 | 174 | 33 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | GLPG1690 600 mg | 9 | 174 | 10 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | GLPG1690 200 mg | 3 | 175 | 3 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | Placebo | 2 | 174 | 2 |
| other | Nausea | Gastrointestinal disorders | GLPG1690 600 mg | 16 | 174 | 18 |
| other | Nausea | Gastrointestinal disorders | GLPG1690 200 mg | 14 | 175 | 20 |
| other | Nausea | Gastrointestinal disorders | Placebo | 10 | 174 | 14 |
| other | Fatigue | General disorders | GLPG1690 600 mg | 10 | 174 | 10 |
| other | Fatigue | General disorders | GLPG1690 200 mg | 9 | 175 | 12 |
| other | Fatigue | General disorders | Placebo | 6 | 174 | 7 |
| other | Bronchitis | Infections and infestations | GLPG1690 600 mg | 8 | 174 | 10 |
| other | Bronchitis | Infections and infestations | GLPG1690 200 mg | 11 | 175 | 13 |
| other | Bronchitis | Infections and infestations | Placebo | 4 | 174 | 4 |
| other | Nasopharyngitis | Infections and infestations | GLPG1690 600 mg | 11 | 174 | 14 |
| other | Nasopharyngitis | Infections and infestations | GLPG1690 200 mg | 7 | 175 | 10 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 10 | 174 | 11 |
| other | Upper respiratory tract infection | Infections and infestations | GLPG1690 600 mg | 10 | 174 | 10 |
| other | Upper respiratory tract infection | Infections and infestations | GLPG1690 200 mg | 12 | 175 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03711162/events